We are live on ! Find out more
HI

Humankind Investments Portfolio holdings

AUM $175M
1-Year Est. Return 14.3%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+14.3%
3 Year Est. Return
+46.43%
5 Year Est. Return
+54.92%
10 Year Est. Return
AUM
$377M
AUM Growth
-$1.21M
Cap. Flow
-$8.07M
Cap. Flow %
-2.14%
Top 10 Hldgs %
64.66%
Holding
168
New
29
Increased
45
Reduced
51
Closed
28

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$2.22M
2
CL icon
Colgate-Palmolive
CL
+$1.39M
3
ABT icon
Abbott
ABT
+$1.11M
4
CI icon
Cigna
CI
+$945K
5
BAX icon
Baxter International
BAX
+$738K

Top Sells

Rank Stock Value
1
VNQ icon
Vanguard Real Estate ETF
VNQ
+$3.37M
2
MSFT icon
Microsoft
MSFT
+$2.29M
3
AAPL icon
Apple
AAPL
+$1.72M
4
ADM icon
Archer Daniels Midland
ADM
+$1.56M
5
ECL icon
Ecolab
ECL
+$1.52M

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 12%
3 Consumer Staples 4.93%
4 Communication Services 2.82%
5 Materials 2.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADM icon
26
Archer Daniels Midland
ADM
$37.4B
$2.2M 0.58%
36,326
-25,499
-41% -$1.56M
PFE icon
27
Pfizer
PFE
$148B
$2.18M 0.58%
77,944
-22,153
-22% -$610K
INTC icon
28
Intel
INTC
$509B
$2.1M 0.56%
+67,783
New +$2.22M
CL icon
29
Colgate-Palmolive
CL
$73.9B
$1.97M 0.52%
20,263
+15,065
+290% +$1.39M
CTVA icon
30
Corteva
CTVA
$51.3B
$1.84M 0.49%
34,183
-11,671
-25% -$643K
BDX icon
31
Becton Dickinson
BDX
$48.7B
$1.62M 0.43%
6,930
+2,335
+51% +$550K
SYK icon
32
Stryker
SYK
$129B
$1.56M 0.41%
4,587
+1,327
+41% +$449K
ABT icon
33
Abbott
ABT
$186B
$1.52M 0.4%
14,621
+10,466
+252% +$1.11M
AMGN icon
34
Amgen
AMGN
$218B
$1.51M 0.4%
4,847
+783
+19% +$230K
WMT icon
35
Walmart Inc
WMT
$887B
$1.51M 0.4%
22,266
-5,883
-21% -$370K
CI icon
36
Cigna
CI
$72.8B
$1.5M 0.4%
4,534
+2,741
+153% +$945K
BG icon
37
Bunge Global
BG
$20.9B
$1.35M 0.36%
12,655
-11,205
-47% -$1.18M
UNH icon
38
UnitedHealth
UNH
$367B
$1.32M 0.35%
2,598
-520
-17% -$255K
HCA icon
39
HCA Healthcare
HCA
$88.2B
$1.32M 0.35%
4,113
-149
-3% -$48.4K
CF icon
40
CF Industries
CF
$17.8B
$1.31M 0.35%
17,666
+2,381
+16% +$185K
GEHC icon
41
GE HealthCare
GEHC
$31.8B
$1.27M 0.34%
16,350
+4,309
+36% +$351K
ECL icon
42
Ecolab
ECL
$79.3B
$1.27M 0.34%
5,342
-6,559
-55% -$1.52M
HPQ icon
43
HP
HPQ
$26B
$1.26M 0.33%
36,022
+11,187
+45% +$355K
VZ icon
44
Verizon
VZ
$194B
$1.26M 0.33%
30,574
-15,624
-34% -$630K
LH icon
45
Labcorp
LH
$25.5B
$1.26M 0.33%
6,175
+2,845
+85% +$579K
DELL icon
46
Dell
DELL
$289B
$1.24M 0.33%
9,016
+4,378
+94% +$587K
T icon
47
AT&T
T
$161B
$1.23M 0.33%
64,567
+18,896
+41% +$329K
BMY icon
48
Bristol-Myers Squibb
BMY
$131B
$1.21M 0.32%
29,170
+1,431
+5% +$64K
TMO icon
49
Thermo Fisher Scientific
TMO
$213B
$1.14M 0.3%
2,066
+392
+23% +$225K
BAX icon
50
Baxter International
BAX
$14.1B
$1.09M 0.29%
32,726
+20,013
+157% +$738K

Similar funds

Humankind Investments's Q2 2024 Portfolio in Review

As of Q2 2024, Humankind Investments held 168 positions worth $377M, down 0.32% from $378M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Humankind Investments's Q2 2024 filing shows 29 new, 45 increased, 51 reduced and 28 closed positions. Its largest new stake was Intel: 67,783 shares worth $2.1M. The largest sale was Vanguard Real Estate ETF, an estimated $3.37M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Humankind Investments's largest Q2 2024 buy was Intel: 67,783 shares worth $2.1M.
  • Humankind Investments added most to Colgate-Palmolive in Q2 2024, an estimated $1.39M increase.
  • Humankind Investments's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.29M.
  • Humankind Investments fully exited Vanguard Real Estate ETF in Q2 2024, selling an estimated $3.37M.
  • Humankind Investments's ten largest holdings make up 65% of its $377M portfolio in Q2 2024.
  • Humankind Investments opened 29 new positions and closed 28 in Q2 2024.
  • Humankind Investments's portfolio value fell 0.32% quarter-over-quarter to $377M.

Based on Humankind Investments's 13F filing for Q2 2024, filed 12 Aug 2024.